Blood test may replace tumor biopsies for lung cancer monitoring

NCT ID NCT00213798

Completed Knowledge-focused Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a simple blood test can monitor lung cancer progression without needing to sample the tumor directly. Researchers checked for genetic changes in the blood of 200 lung cancer patients. The goal was to see if this non-invasive method could track how the disease changes over time.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung neoplasm non-small cell lung carcinoma small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON-SMALL CELL LUNG CARCINOMA SMALL CELL LUNG CANCER

Contacts and locations

Locations

Service de Chirurgie Thoracique, Hôpital Civil

Strasbourg, 67091, France
Service de Pneumologie, Hôpital Civil

Strasbourg, 67091, France
Service de Pneumologie, Hôpital Lyautey

Strasbourg, 67000, France
Service de Pneumologie, Hôpital de Hautepierre

Strasbourg, 67098, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.